These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32029960)

  • 1. Influence of cytochrome P450 3A5 (CYP3A5) genetic polymorphism on dose-adjusted plasma levels of carbamazepine in epileptic patients in South Indian population.
    Ganesapandian M; Ramasamy K; Adithan S; Narayan SK
    Indian J Pharmacol; 2019; 51(6):384-388. PubMed ID: 32029960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of CYP3A5 and UGT2B7 variants on steady-state carbamazepine concentrations in Chinese epileptic patients.
    Lu Q; Huang YT; Shu Y; Xu P; Xiang DX; Qu Q; Qu J
    Medicine (Baltimore); 2018 Jul; 97(30):e11662. PubMed ID: 30045320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of CYP3A5 genotypes on the pharmacokinetics of carbamazepine when used as monotherapy or co-administered with phenytoin, phenobarbital or valproic acid in Thai patients.
    Panomvana D; Traiyawong T; Towanabut S
    J Pharm Pharm Sci; 2013; 16(4):502-10. PubMed ID: 24210059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy.
    Wang P; Yin T; Ma HY; Liu DQ; Sheng YH; Wang C; Zhou BT
    Epilepsy Res; 2015 Nov; 117():52-7. PubMed ID: 26421491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of CYP3A5*3 genotype on serum carbamazepine concentrations at steady-state in Korean epileptic patients.
    Park PW; Seo YH; Ahn JY; Kim KA; Park JY
    J Clin Pharm Ther; 2009 Oct; 34(5):569-74. PubMed ID: 19744012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First Analysis of the Association Between CYP3A4/5, ABCB1 Genetic Polymorphisms and Oxcarbazepine Metabolism and Transport in Chinese Epileptic Patients with Oxcarbazepine Monotherapy and Bitherapy.
    Wang P; Yin T; Ma HY; Liu DQ; Sheng YA; Zhou BT
    J Pharm Pharm Sci; 2015; 18(3):256-65. PubMed ID: 26517132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of EPHX1, SCN1A and CYP3A4 genetic polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy.
    Yun W; Zhang F; Hu C; Luo X; Xue P; Wang J; Ge Y; Meng H; Guo Y
    Epilepsy Res; 2013 Dec; 107(3):231-7. PubMed ID: 24125961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of major transporter and metabolizing enzyme gene polymorphisms on carbamazepine metabolism in Chinese patients with epilepsy.
    Zhu X; Yun W; Sun X; Qiu F; Zhao L; Guo Y
    Pharmacogenomics; 2014; 15(15):1867-79. PubMed ID: 25495409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics of Carbamazepine: A Systematic Review on CYP3A4 and CYP3A5 Polymorphisms.
    Riffi R; Boughrara W; Chentouf A; Ilias W; Brahim NMT; Berrebbah AA; Belhoucine F
    CNS Neurol Disord Drug Targets; 2024; 23(12):1463-1473. PubMed ID: 38859787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of ABCB1, CYP3A4, EPHX1, FAS, SCN1A, MICA, and BAG6 polymorphisms with the risk of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Chinese Han patients with epilepsy.
    He XJ; Jian LY; He XL; Tang M; Wu Y; Xu YY; Sun XJ; Zhao LM
    Epilepsia; 2014 Aug; 55(8):1301-6. PubMed ID: 24861996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphic Variants of SCN1A and EPHX1 Influence Plasma Carbamazepine Concentration, Metabolism and Pharmacoresistance in a Population of Kosovar Albanian Epileptic Patients.
    Daci A; Beretta G; Vllasaliu D; Shala A; Govori V; Norata GD; Krasniqi S
    PLoS One; 2015; 10(11):e0142408. PubMed ID: 26555147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of allele CYP3A4*16 does not have any bearing on carbamazepine-induced adverse drug reactions in North Indian people with epilepsy.
    Garg VK; Goyal MK; Khullar M; Saikia B; Medhi B; Prakash A; Prabhat N; Tandyala N; Mahesh KV; Kharbanda PS; Prabhakar S; Modi M; Lal V; Shree R; Sachdeva J
    Indian J Pharmacol; 2020; 52(5):378-382. PubMed ID: 33283769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between CYP3A4, CYP3A5 and SCN1A polymorphisms and carbamazepine metabolism in epilepsy: A meta-analysis.
    Zhao GX; Zhang Z; Cai WK; Shen ML; Wang P; He GH
    Epilepsy Res; 2021 Jul; 173():106615. PubMed ID: 33756436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy.
    Puranik YG; Birnbaum AK; Marino SE; Ahmed G; Cloyd JC; Remmel RP; Leppik IE; Lamba JK
    Pharmacogenomics; 2013 Jan; 14(1):35-45. PubMed ID: 23252947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population estimation regarding the effects of cytochrome P450 2C19 and 3A5 polymorphisms on zonisamide clearance.
    Okada Y; Seo T; Ishitsu T; Wanibuchi A; Hashimoto N; Higa Y; Nakagawa K
    Ther Drug Monit; 2008 Aug; 30(4):540-3. PubMed ID: 18641551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of CYP3A5 polymorphism on trough concentrations and outcomes of tacrolimus minimization during the early period after kidney transplantation.
    Yaowakulpatana K; Vadcharavivad S; Ingsathit A; Areepium N; Kantachuvesiri S; Phakdeekitcharoen B; Sukasem C; Sra-Ium S; Sumethkul V; Kitiyakara C
    Eur J Clin Pharmacol; 2016 Mar; 72(3):277-83. PubMed ID: 26635230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum carbamazepine concentrations in elderly patients: a case-matched pharmacokinetic evaluation based on therapeutic drug monitoring data.
    Battino D; Croci D; Rossini A; Messina S; Mamoli D; Perucca E
    Epilepsia; 2003 Jul; 44(7):923-9. PubMed ID: 12823575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia.
    Egbelakin A; Ferguson MJ; MacGill EA; Lehmann AS; Topletz AR; Quinney SK; Li L; McCammack KC; Hall SD; Renbarger JL
    Pediatr Blood Cancer; 2011 Mar; 56(3):361-7. PubMed ID: 21225912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbamazepine-risperidone interactions in patients with epilepsy.
    Mula M; Monaco F
    Clin Neuropharmacol; 2002; 25(2):97-100. PubMed ID: 11981236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbamazepine 10,11-epoxidation in human liver microsomes: influence of the
    Miyata-Nozaka Y; Zain SM; Taguchi M; Shigeyama M; Isobe T; Hanioka N
    Pharmazie; 2017 Dec; 72(12):747-750. PubMed ID: 29441960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.